When cytology may be considered
- Investigation of blood in the urine in selected patients
- Follow-up of some patients previously treated for bladder cancer
- An abnormal-looking area or ongoing concern despite other tests
- Assessment directed by a urologist or multidisciplinary team
How the sample is assessed
- A urine sample is collected according to the laboratory instructions
- Cells in the sample are examined by specialist laboratory staff
- The report may describe negative, atypical, suspicious or malignant findings
- Results are interpreted alongside cystoscopy, imaging and clinical history
Limits of urine cytology
- It is generally more useful for detecting high-grade disease than low-grade tumours
- Inflammation, infection or recent instrumentation can affect appearances
- A negative result does not rule out bladder cancer
- An abnormal result may require further investigation rather than providing a diagnosis alone
How this fits your care: Visible blood in urine should be assessed promptly. Urine cytology is only one possible part of that assessment.
Discussing the next step
Mr Syed Ali Shahzad can review your symptoms, previous results and imaging before explaining whether this investigation is appropriate and how the result may affect treatment planning. Tests are arranged through the relevant hospital pathway.
Clinical information reference: NHS information on diagnosing bladder cancer. This page provides general information and does not replace individual medical advice.